# HSEF v5.3 review: Xist Smart-Scaffold Hypothesis

> Sources: 65 primary reports; claims: 70; verified: 70; unverified: 0. Verification is bounded attribution. Access: 9 partial-body and 56 complete abstract/status examinations. Literature cutoff: 2026-10-09; source examination UTC date: 2026-10-09. No complete-paper audit or blinded calibration claimed.
> **Adversarial review:** Generated by Sol 6.1; adversarially reviewed by Claude Opus 5.5 (Anthropic) on 2026-10-14. 4 corrections applied (see ADVERSARIAL REVIEW AND APPROVAL). Status: **Approved as revised.**

## AT A GLANCE

**Xist is a causal silencing RNA, but direct continuous tethering of both Polycomb complexes is not established.**

| Level | Confidence | Causal role | Momentum | Stability | Divergence |
|---|---|---|---|---|---|
| Γ — Mechanistically plausible, partial system support | Moderate | epiphenomenon | Mechanistic only | Stable | Contested |

**Deciding experiment:** At native female Xist expression, selectively disrupt a mapped direct RNA interface for each PRC while preserving SPEN, hnRNPK, RNA abundance and localization; compare initiation with expression-matched interface rescue and acute nascent allele-specific transcription.

**Belief versus evidence:** The preregistered primary-subclaim rule uses SC2, giving Γ for direct continuous Polycomb scaffolding. SC1 is Η within initiation-competent mammalian contexts, while SC3 is Γ and SC4 Β for their stronger mechanism claims. Weakest-link sensitivity is Β. Evidence for Xist necessity and modular Polycomb causality is retained and cannot replace the nominal structural claim.

**Best-supported rival:** Modular effector pathways with a PRC1-first Polycomb cascade. Pintacuda KI-domain tether controls identify adapter recruitment, while Bowness separation-of-function plus acute PCGF depletion distinguishes parallel effector causality from a generic RNA cloud. Markaki and Jachowicz add spatial amplification without establishing a continuous direct PRC tether.

## COMPETING MECHANISTIC MODELS

**Rank 1: Modular effector pathways with a PRC1-first Polycomb cascade (Ζ).** SPEN and Polycomb can contribute in parallel; hnRNPK bridges Xist to PCGF3/5, followed by catalytic chromatin recruitment. Recombinant KI-dependent bridging, native B/C perturbation and SPEN-SPOC/PCGF combined depletion resolve alternatives. Human domain independence and direct PRC2 UV contacts prevent a universal single-cascade claim.

**Rank 2: Xist-seeded protein assembly and spatial amplification (Ε).** Sparse RNA nucleates enriched effectors; compaction improves access to genes. Calibrated imaging, SPEN assembly perturbations and B-repeat effects support this defined mouse setting. Assembly is not proof of LLPS, and quantitative labeling plus lineage transfer remain limitations.

**Rank 3: Dynamic RNA contact and catalytic release (Ε).** PRC2 contacts RNA transiently while folding/release regulates catalytic access. Native rG4 mutations preserve contact but deregulate marks and repression. Recruitment preservation and one main platform do not establish that this is the sole route.

**Rank 4: Chromatin feedback and redundant maintenance (Ε).** Marks, architecture and RNA spreading reinforce one another with lineage-dependent memory. Repeat B reciprocity, EED differentiation effects and somatic XIST deletion support defined feedback. Feedback alone does not explain initial SPEN-dependent repression or all human B-cell maintenance.

**Rank 5: Direct continuous Polycomb smart scaffold (Γ).** Xist directly and continuously tethers both PRCs as the initiating silencing structure. RepA affinity, RNA association and direct PRC2 contact provide a plausible molecular foothold. Bridged recruitment, sparse RNA and retained initial repression without B/C-dependent marks oppose the full conjunction.

The tournament does not alter the nominal level. Compatible pathways and flexible alternatives are not automatically proved by explaining observations.

## FULL REVIEW

### Registered claim and scope

Xist RNA directly binds and structurally tethers PRC1 and PRC2 across the inactive X chromosome, and this continuous Polycomb scaffold establishes X-linked silencing.

The scaffold mechanism SC2 sets the nominal level, with SC3/SC4 necessity and continuous coating reported separately. Xist necessity and ectopic sufficiency SC1 cannot substitute for direct Polycomb tethering. Repeat modules, species, stage and cell lineage are fixed before outcomes.

Selection: public-interest rank 47 from the editorial ranking compiled 2026-09-23; categorical prior verdicts were visible. Private fresh review; earlier documents are preserved.

### Evidence and causal interpretation

The historical discovery evidence established Xist as an Xi-associated nuclear RNA before it established a causal mechanism. Native gene targeting and parent-of-origin/XO controls moved the initiating-RNA claim beyond association. Timed cDNA induction then demonstrated a developmental window for long-range cis repression and a transition toward RNA-independent maintenance. Neither discovery nor induction identifies the molecular identity of a Polycomb scaffold. PMID2034279 PMID1423610 PMID8425217 PMID8538762 PMID9009199 PMID10882105

RNA localization is separable from repression. A-repeat-deficient RNA still spreads but fails to silence; a hypomorphic Xist allele also coats without fully establishing stable repression. Endogenous Tsix-driven ectopic Xist shows X-dose and sex dependence despite comparable coating. These controls are especially important because the usual visual cloud can otherwise be mistaken for the causal structure. PMID11780141 PMID21613321 PMID26739568 PMID20657585

The direct recruitment hypothesis has real biochemical evidence. Zhao reported structured RepA binding to purified PRC2 and ectopic recruitment. Original passages also show severe loss of full-length Xist induction after RepA depletion and retained silencing in some Xist-positive PRC2-deficient cells. The experiment therefore cannot cleanly attribute silencing failure to an isolated PRC2 tether. PRC2 RNA-binding studies show both motif preference and broad promiscuity, while RNA competes with nucleosome substrate binding. These findings qualify specificity; they do not make all direct contacts impossible. PMID18974356 PMID24077223 PMID25601759 PMID28306504 PMID29058709

The best-resolved Polycomb recruitment route begins with a protein bridge. PCGF3/5 loss removes Xi-specific Polycomb marks, with single-PCGF and in-vivo sex controls. Pintacuda purified the hnRNPK-PCGF3 interaction, mapped its KI dependence and restored recruitment and allelic repression by tethering hnRNPK to an RNA lacking its recruitment domain. GFP-only and KI-deficient constructs fail. These experiments distinguish an adapter from a generic RNP association and place PRC1-catalyzed H2A ubiquitination upstream of much PRC2 recruitment in mouse models. PMID28596365 PMID29220657 PMID16763550

The causal role of Polycomb is neither universally absent nor a single obligatory initiation switch. Bousard native-locus B/C mutants retain RNA stability and cloud intensity but lose global marks while retaining most early silencing. Some promoter marks remain, and repression is modestly relaxed. Other gene-class and repeat-deletion studies show stronger dependence. Differences in gene expression, pre-existing marks, induction level, XX/XY context and stage must be retained rather than pooled into one null result. PMID31456285 PMID31311937 PMID31175153 PMID30827740 PMID33605056

SPEN is a major endogenous initiating effector, but whole-protein loss also changes Xist upregulation, localization and turnover. Bowness therefore used SPOC separation-of-function mutations and acute PCGF degradation, then a targeted RNA-domain deletion as a control for global Polycomb effects. Combined pathway loss abolishes repression despite comparable RNA abundance, supporting parallel contributions. This prevents overclaiming that all Polycomb effects are simply downstream of SPEN. PMID32025035 PMID34853312 PMID35584662 PMID25915022

Quantitative spatial evidence changes the meaning of coating. Markaki calibrated tagged RNA against GFP nanocages, estimated roughly two RNAs per focus and found locally confined foci with abundant SPEN. These are model-based estimates with labeling assumptions, not direct counts of every molecule. B-repeat loss reduces compaction and preferentially impairs later-silencing genes. Independent SHARP amplification and STORM studies likewise support protein action beyond directly occupied RNA sites. RNAPII can still diffuse into the territory, further opposing simple physical-exclusion interpretations. PMID34813726 PMID35301492 PMID26195790 PMID37291424

A newer native rG4 study deserves explicit weight against an over-simple no-contact verdict. The clean 3-prime mutant preserves Xist expression and UV-supported PRC2 contact, yet increases misplaced H3K27me3 and compromises repression. Direct interaction can therefore regulate catalytic release and spatial progression without functioning as a permanent tether. In contrast, formaldehyde-RIP in a 2025 isogenic Airn/Xist comparison — performed on ectopically expressed transgenes in mouse embryonic stem cells, the same cell system as the rG4 work — finds weak PRC2 association and stronger hnRNPK-linked PRC1 association. Different assay chemistry and construct context (endogenous Xist versus an ectopic transgene) remain an unresolved separator; neither result should silently erase the other. PMID38759625 PMID40118040

Human and maintenance boundaries matter. HT1080 domain deletions and inhibitors separate human PRC1 and PRC2 pathways even at an X-linked insertion, but ectopic cancer-cell expression and incomplete global inhibition limit transfer. Diploid somatic XIST deletion reduces marks with little reactivation, whereas adult B cells continuously need XIST for a defined immune-gene subset. EED loss likewise reveals differentiation-dependent memory rather than general indispensability. These are narrower causal pathways and redundant epigenetic layers, not confirmation of one continuous initiating scaffold. PMID33750950 PMID33745031 PMID33735607 PMID16415857

The m6A literature illustrates why recent negative controls belong in the review. Knockdown and synthetic tether rescue originally supported a requirement. Acute METTL3 degradation instead accelerates silencing through increased Xist stability and NEXT-dependent turnover, reducing transcript-wide and timing confounding. This revision strengthens the case for mechanism-specific perturbation rather than substituting a mark or RNA-binding association for function. PMID27602518 PMID40926104

## HYPOTHESIS STATE EVALUATION FRAMEWORK (HSEF v5.3)

<!-- consensus-consistency-2026-10-09 -->
### Consensus provenance reconciliation — 9 October 2026

Case-specific Consensus discovery records were located and linked to this final edition. This supplements the review's provenance; it leaves the original assessed claim, grades and source counts intact. Provider summaries and full-text badges do not establish examination of original primary passages by this reviewer. Source access and incorporation retain the limits stated in the original methods and any dated research update.

Recorded evidence artifacts:

- `deliverables/hsef_v53_popularity_ranks_46_50_2026-10-09/xist-smart-scaffold/consensus-anchor-queries-search-log.json`
- `deliverables/hsef_v53_popularity_ranks_46_50_2026-10-09/xist-smart-scaffold/consensus-anchor-queries.json`
- `deliverables/hsef_v53_popularity_ranks_46_50_2026-10-09/xist-smart-scaffold/consensus/browser-pro-broad.txt`
- `deliverables/hsef_v53_popularity_ranks_46_50_2026-10-09/xist-smart-scaffold/consensus/browser-pro-targeted.txt`
- `deliverables/hsef_v53_popularity_ranks_46_50_2026-10-09/xist-smart-scaffold/consensus/reconciliation.md`

Reported usage is preserved in the linked source-specific records; query counts and original-passage comparisons are different measures.

No earlier adversarial approval exists for this case; this provenance supplement is not a new independent or blinded adjudication. No score or confidence change is made by this reconciliation.
<!-- end-consensus-consistency -->


### Subclaim matrix and aggregation

| Subclaim | Scope | Level | Decision |
|---|---|---|---|
| SC1 Xist expression is necessary in cis and sufficient from an ectopic locus to establish chromosome-wide silencing. | mouse and human lineage, initiation and maintenance separately | Η | Native Xist deletions with dosage controls, induction sufficiency in defined competent cells and independently identified endogenous SPEN pathways converge on a causal initiating RNA. Human naive dampening and lineage-specific maintenance restrict scope; this is not universal silencing sufficiency in any cell. |
| SC2 Xist directly physically tethers PRC1 and PRC2 as a structural scaffold. | native RNA abundance, PRC identity and stage | Γ | Direct PRC2 contact has biochemical and native UV-RIP support, but neither direct binding to both PRCs nor continuous structural tethering is isolated as the silencing mechanism. hnRNPK bridging, PRC1-first catalysis and dynamic release remain better supported. In-vitro contact cannot carry the registered conjunction above Γ. |
| SC3 Polycomb scaffolding is necessary to initiate X-linked transcriptional silencing. | initiation stage and gene set prespecified | Γ | Polycomb has causal, gene- and stage-dependent contributions, yet B/C deletion retains substantial initial silencing and matched SPEN/Polycomb loss supports parallel contributions. No positive experiment establishes necessity of a continuous direct scaffold for initiation. |
| SC4 Xist coats silenced Xi loci as a continuous physical scaffold. | native Xi territory and molecule abundance | Β | Population coating and colocalization support broad association only. Sparse calibrated foci, protein amplification and accessible RNAPII argue against reifying a uniform continuous coat. This positive mechanistic subclaim stays at Β; that grade is not a denial of Xist localization. |

Preregistered aggregation: primary-subclaim. The preregistered primary-subclaim rule uses SC2, giving Γ for direct continuous Polycomb scaffolding. SC1 is Η within initiation-competent mammalian contexts, while SC3 is Γ and SC4 Β for their stronger mechanism claims. Weakest-link sensitivity is Β. Evidence for Xist necessity and modular Polycomb causality is retained and cannot replace the nominal structural claim. Sensitivities: weakest-link Β; primary-subclaim Γ; scope-matched Γ.

### Decisive-perturbation inventory and causal tally

[1] XIST perturbation supports X-linked dampening and some autosomal targeting in naive cells. Dampening and dispersed localization differ from complete cis silencing; no continuous Polycomb scaffold is isolated.

[2] Interactome and knockdowns identify modular SPEN and hnRNPK functions coupled to differentiation. Crosslinked association does not establish every interactor as a direct RNA binder or continuous tether.

[3] Direct SHARP association and HDAC3/SMRT perturbation connect Xist to transcriptional repression and Pol II loss. PRC2 recruitment dependence on this pathway does not itself prove direct Xist-PRC2 contact or a single serial cascade.

[5] An ERV element replaces A-repeat binding to SPEN and supports strictly local cis repression. Local rescue cannot establish full chromosome silencing or Polycomb as the initiating scaffold.

[6] Repeat perturbations distinguish SPEN-dependent and pre-Polycomb-marked gene classes with different kinetics. Predictive genomic features remain correlates; classes do not imply universal Polycomb necessity.

[7] Xist-dependent EED/EZH2 and H3K27 methylation can occur independently of Xist silencing function. Recruitment and methylation are not sufficient for silencing; no continuous tether measured.

[8] Calibrated sparse Xist foci nucleate many SPEN molecules; B-repeat loss impairs compaction and especially late silencing. Molecule estimates depend on labeling calibration; local assemblies and protein gradients are not a continuous RNA coat.

[9] RNA abundance, architecture and autonomously Polycomb-binding CpG islands shape broad modification domains. Other lncRNAs and correlated domain patterns cannot alone identify the Xist recruitment mechanism.

[11] XIST promoter deletion reduces Polycomb marks without appreciable gene reactivation in the tested cells. Maintenance redundancy is lineage-specific; it does not erase XIST initiation necessity.

[12] PCGF3/5 double loss abolishes Xi Polycomb marks and compromises silencing; single-loss controls and embryos support a PRC1-first route. Global PCGF loss and transgenic induction are not a direct RNA interface-specific test; phenotype does not prove PRC2-first scaffolding.

[13] HDAC3 activity and early deacetylation accompany silencing before Polycomb spreads into genes. Temporal order and HDAC3 perturbation do not require that all Polycomb activity lies downstream of SPEN.

[14] SPEN is required for embryonic initiation, disengages after silencing, and SPOC tethering supports repression. SPEN is dispensable for much neural maintenance; total SPEN loss also alters RNA localization and does not isolate its effector domain.

[15] Silent Xi persists without EED in undifferentiated cells but reactivates upon differentiation. A differentiation-dependent memory role is not general Polycomb dispensability at initiation.

[16] SPEN loss impairs Xist upregulation and concomitant Tsix removal rescues that defect. Silencing failure after SPEN loss partly reflects altered Xist abundance rather than only downstream repression.

[17] Xist regulatory-region disruption and cohesin degradation link stage-specific megadomains to local regulation. Chromosome folding boundaries are not direct Polycomb tethers and may be strain-specific.

[18] Whole XIST deletion reactivates genes; segmental deletion maps maintenance functions including exon 5. A cancer cell line and maintenance context cannot fix all human developmental domains or the direct PRC binding interface.

[19] RNAPII can enter the Xist territory; apparent depletion reflects reduced chromatin-bound transcription machinery. Accessible diffusion does not exclude all local protein assemblies or every mature Xi physical effect.

[20] Mutant Xist coats the X yet establishes incomplete and unstable silencing. Coating is insufficient; the allele perturbs more than a selective Polycomb interface.

[21] SMCHD1 recruitment depends on the Xist-hnRNPK-PRC1/H2AK119ub pathway and lacks specific RNA binding in assays. This supports indirect downstream recruitment rather than proving PRC2 never contacts Xist.

[23] Xist spreading exploits pre-existing 3D proximity and its silencing domain to access active regions. Population occupancy maps do not show simultaneous uniform coverage in individual cells.

[24] Comparable Xist induction/coating yields sex- and X-dose-dependent differences in silencing. Coating alone is insufficient; ectopic Tsix-driven expression does not represent every normal initiation condition.

[25] A-repeat regulates spliced Xist accumulation and random choice. A-repeat deletion has an RNA-processing confound and cannot be read solely as selective PRC2 binding loss.

[26] B/C-deficient Xist retains silencing despite loss of H3K27me3 and H4K20me1 accumulation. Retained initiation does not exclude stabilization or gene-specific Polycomb dependence.

[27] hnRNPK directly bridges B-repeat to PCGF3-PRC1; KI-deficient and GFP tether controls fail while hnRNPK restores marks and silencing. Synthetic tethering is a mechanistic rescue within engineered cells, not proof of a direct continuous RNA interaction with both PRCs.

[28] Orthogonal RNA structure and interaction methods plus A-repeat relocation show modular RNP architecture. A structured modular RNA is not automatically a chromosome-wide Polycomb scaffold.

[29] B/C loss removes PCGF3/5 association and global marks while most initial silencing persists; RNA stability/coating and A-repeat controls distinguish effects. Induced XY expression exceeds native maintenance signal and residual promoter marks remain; modest silencing deficits cannot be described as zero Polycomb function.

[30] CIZ1 loss disperses Xist in somatic lineages and re-expression restores focal localization. Anchoring to a matrix is not direct binding of Xist to both PRCs; viable mutants restrict universality.

[31] Cohesin loss greatly changes Xi structure with little repression change, whereas retention disrupts Xist spreading and silencing. Structure-function dependence is asymmetric and cannot be reduced to all structural perturbations causing transcription loss.

[32] Repeat E/CIZ1 loss and CIZ1 overexpression disperse Xist with reduced H3K27me3. Dose-sensitive local anchoring does not establish continuous chromosome-wide RNA occupancy.

[33] Broad Xist interactome and multi-factor inhibition reveal layered repression and cohesin eviction. Association/proteomic sensitivity and multi-target intervention do not identify a unique direct PRC scaffold.

[34] SMCHD1 loss preserves intermediate compartments, impairs regional Xist spread and silencing. Architectural contribution is downstream or cooperative, not continuous direct Xist-PRC tethering.

[35] SPEN RBM15 and WTAP perturbations impair establishment and factors colocalize with Xist. shRNA and colocalization can involve RNA abundance or indirect effects; later acute m6A tests revise necessity.

[37] m6A machinery knockdown impairs XIST repression and synthetic YTHDC1 tethering rescues it. Transcript-wide effects and engineered rescue do not establish native m6A necessity; acute METTL3 depletion produces a different result.

[38] XIST continuously restrains a subset of immune genes through lineage-specific repression with TRIM28. B-cell maintenance differs from diploid somatic redundancy; continual XIST requirement is not a continuous Polycomb scaffold.

[39] Parent-of-origin deletion gives dosage-compensation failure and female embryonic lethality; XO and male controls resolve dosage effects. These controls establish Xist function without distinguishing direct PRC tethering from modular recruitment.

[42] Xist initiates long-range cis repression within a developmental window and later repression becomes less Xist-dependent. Ectopic sufficiency is context-limited; irreversible maintenance does not require continuous RNA scaffold persistence.

[43] A-repeat loss preserves localization/spreading but abolishes silencing, separating functions. Engineered cDNA-domain behavior cannot alone identify native PRC recruitment interfaces.

[44] Xist gene targeting demonstrates requirement for normal XCI. The abstract is brief and gives no direct Polycomb-scaffold test; no complete body audit here.

[45] Parallel SPEN and Polycomb contributions are separated; combined loss abolishes repression with comparable Xist abundance and RNA-domain controls. Residual localization defects and chromosome-loss selection constrain late endpoints; Polycomb causality does not identify a continuous scaffold.

[46] Acute m6A loss accelerates XCI with increased Xist stability; NEXT-mediated turnover is YTHDC1-independent. This revises m6A-necessity interpretation, not the need for Xist itself or all RNA modifications.

[47] Non-stoichiometric SHARP amplification represses regions without direct Xist occupancy; increased RNA also spreads to autosomes. Protein self-assembly need not constitute phase separation or a uniform RNA coat; high expression changes specificity.

[48] A-repeat screening identifies silencing function and effects on Xist transcription. Regulatory DNA/RNA-production effects complicate reading deletions as isolated scaffold lesions.

[49] Old and new RNA couple physically and SPEN affects localization stability and synthesis-degradation feedback. Tagging and optical resolution constrain individual trajectories; dynamics alone cannot define a causal continuous scaffold.

[50] G-tract RNA competes PRC2 off nucleosomes and targeted CDKN2A RNA releases repression. Other genes and tumor contexts do not imply every Xist interaction is inhibitory; linked correction metadata is retained.

[53] RNA and chromatin/nucleosomes compete for PRC2 and RNA loss alters recruitment patterns. RNase-based chromatin inference requires later normalization controls; competition does not forbid transient RNA-mediated regulation.

[55] RNase-induced background DNA redistribution can artifactually reduce PRC2 and H3K27me3 ChIP occupancy. The artifact applies to this assay, not all RNA-binding or recruitment experiments.

[56] Dispersed EZH2 residues mediate RNA recognition with conserved quadruplex preference. In-vitro separation of binding does not alone prove Xist-specific silencing and both-complex structural tethering.

[57] Linker DNA dominates substrate binding and RNA competitively sequesters PRC2 from nucleosomes. A purified competition model cannot alone settle the full native Xi recruitment cascade.

[58] Structured RepA binds recombinant PRC2; knockdown also severely impairs full-length Xist induction, and PRC2-deficient Xist-positive cells can retain silencing. Expression confounding and indirect cellular associations prevent the knockdown from isolating a direct necessary continuous scaffold.

[59] RING1B-dependent H2A ubiquitination persists without EED/H3K27me3 and is independent of silencing. Independent PRC1 recruitment in this context does not imply all PRC complexes act independently in every lineage.

[60] Different RNA regions and enzymatic inhibitors separate human PRC1/SMCHD1 and PRC2/macroH2A pathways at autosomal and X-linked integration sites. Cancer cells ectopic induction and incomplete global inhibition limit species-general transfer; independence does not demonstrate direct binding.

[61] Airn deposits Polycomb marks without repression; adding Xist A-repeat restores repression, and native RIP favors hnRNPK-bridged PRC1 association. Formaldehyde RIP detects direct and indirect interactions; weak PRC2 signals do not negate UV-supported contact in a different lineage.

[62] rG4 loss preserves direct UV-supported PRC2 association but deregulates marks and silencing; mutants preserving RNA expression avoid the AF confound. A regulated direct contact supports dynamic catalysis, not direct binding to both complexes or continuous structural tethering; assays need independent replication.

[63] Sparse Xist/PRC2 hubs and reassociation support a dynamic spatial interaction and hit-and-run model. Nonrandom nanoscale proximity is not itself direct molecular binding; finite detection cannot rule out all undetected RNA.

[64] SPEN dominates many genes while Polycomb supports pre-marked genes; LBR and m6A factors have minor tested contributions. Shared Oxford platforms are not wholly independent replications and gene-class dependence opposes universal scaffold necessity.

[65] Repeat B/HNRNPK and Polycomb reciprocally support RNA spreading, silencing and Xi topology. Feedback dependence supports cooperation but does not discriminate a direct continuous tether from adapter recruitment or compaction.

Tally: 56 discriminating contrasts. Null and negative contrasts are discriminators, not positive threshold crossings. Reports and replications are not independent causal lines. Shared cohorts, experimental platforms, transgenic lineages and repeated outcomes do not constitute fully independent causal lines.

### Cap audit, precedence and Β/Γ/Δ boundary

Endogenous deletions/degrons and functional output cross high thresholds for Xist and modular effector subclaims. The simplified-system Γ cap binds transfer from purified PRC2 affinity to the registered direct continuous dual-PRC scaffold. Native opposing results do not become positive Δ evidence merely because the experiment was decisive.

Gamma hard-rule audit: Direct RNA binding, chromatin marks and a visible RNA cloud are distinct measurements; none alone identifies a continuous causal scaffold. Native functional perturbations of Xist, SPEN and Polycomb cross thresholds for those narrower pathways; no positive scaffold-specific perturbation crosses SC2/SC3.

SC2 cap: “Mechanistic plausibility plus in vitro reconstitution or simplified cellular support caps at Γ.” Direct PRC2 contact has biochemical and native UV-RIP support, but neither direct binding to both PRCs nor continuous structural tethering is isolated as the silencing mechanism. hnRNPK bridging, PRC1-first catalysis and dynamic release remain better supported. In-vitro contact cannot carry the registered conjunction above Γ.

SC3 cap: “Mechanistic plausibility plus in vitro reconstitution or simplified cellular support caps at Γ.” Polycomb has causal, gene- and stage-dependent contributions, yet B/C deletion retains substantial initial silencing and matched SPEN/Polycomb loss supports parallel contributions. No positive experiment establishes necessity of a continuous direct scaffold for initiation.

SC4 cap: “Genome-wide association and colocalization without direct perturbation cap at Β.” Population coating and colocalization support broad association only. Sparse calibrated foci, protein amplification and accessible RNAPII argue against reifying a uniform continuous coat. This positive mechanistic subclaim stays at Β; that grade is not a denial of Xist localization.

SC1 field-valid definition: “
- Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype
- Locus-specific disruption of looping with locus-specific effect
- Combinatorial histone-mark perturbation showing direct output dependence
- Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: yes. Native Xist deletions with dosage controls, induction sufficiency in defined competent cells and independently identified endogenous SPEN pathways converge on a causal initiating RNA. Human naive dampening and lineage-specific maintenance restrict scope; this is not universal silencing sufficiency in any cell.

SC2 field-valid definition: “
- Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype
- Locus-specific disruption of looping with locus-specific effect
- Combinatorial histone-mark perturbation showing direct output dependence
- Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Direct PRC2 contact has biochemical and native UV-RIP support, but neither direct binding to both PRCs nor continuous structural tethering is isolated as the silencing mechanism. hnRNPK bridging, PRC1-first catalysis and dynamic release remain better supported. In-vitro contact cannot carry the registered conjunction above Γ.

SC3 field-valid definition: “
- Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype
- Locus-specific disruption of looping with locus-specific effect
- Combinatorial histone-mark perturbation showing direct output dependence
- Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Polycomb has causal, gene- and stage-dependent contributions, yet B/C deletion retains substantial initial silencing and matched SPEN/Polycomb loss supports parallel contributions. No positive experiment establishes necessity of a continuous direct scaffold for initiation.

SC4 field-valid definition: “
- Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype
- Locus-specific disruption of looping with locus-specific effect
- Combinatorial histone-mark perturbation showing direct output dependence
- Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Population coating and colocalization support broad association only. Sparse calibrated foci, protein amplification and accessible RNAPII argue against reifying a uniform continuous coat. This positive mechanistic subclaim stays at Β; that grade is not a denial of Xist localization.

### Upward threshold ladder

SC1 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: yes. 

SC1 Ε: “Requires context-specific causality with clear scope restriction. Many enhancer, condensate, or accessibility claims belong here.” Satisfied: yes. 

SC1 Ζ: “Requires:
- Independent causal tests across loci or systems
- Specificity beyond global transcriptional collapse
- Narrowing of key alternatives” Satisfied: yes. 

SC1 Η: “Requires:
- Robust endogenous causality
- Reproducibility across loci/cell states within scope
- Strong evidence that the proposed mechanism is not a downstream correlate” Satisfied: yes. 

SC1 Θ: “Requires broad explanatory power with minimal contradictions.” Satisfied: no. Native graded Xist induction with separation from regulatory-DNA effects and reproducible necessity/sufficiency across the defined lineages would reach Θ/Ω only if major boundaries were explained.

SC2 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. Selective endogenous disruption of a direct RNA-PRC1/PRC2 tether while preserving Xist abundance, localization, SPEN and adapter functions, with matched rescue and allele-specific nascent repression.

SC3 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. An endogenous scaffold-only lesion must prevent initiation despite intact parallel effectors and restore it upon mechanism-specific rescue.

SC4 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. Quantitative single-cell coverage at native expression plus a selective continuity perturbation must connect continuous physical occupancy to functional repression.

Upper ladder: Upper rungs are live without an RCT. Native Xist alleles, endogenous SPEN/PCGF interventions, graded induction, allele-resolved output and orthogonal proteomic/spatial assays justify Η for the narrow initiating-RNA claim and Ζ for modular recruitment. They do not demonstrate the continuous dual-PRC tether. The missing evidence is mechanism isolation and positive native functional rescue, not clinical randomization.

Independence: Convergence for Xist causality spans genetic dosage controls, temporal RNA induction and independent effector assay classes. Related laboratory lineages are grouped; native functional results narrow alternatives. SC2 lacks a similarly independent positive continuous-tether case.

Native dosage-compensation genetics [39, 44]: Parent-of-origin and XO controls exclude a generic developmental association. Related Xist knockout work shares genetic assumptions.

RNA induction and domain separation [42, 43, 29]: Timed induction and domain-specific preservation of RNA coating separate RNA localization from repression; transgene and promoter-induction limitations remain.

Effector identity and native functional tests [3, 14, 45]: Direct-protein purification and embryo/native SPEN genetics exclude mere mark correlation. Oxford degron studies share parental lines and count as one platform, not several independent lines.

### Falsification and pitfalls

Perturbing the proposed feature leaves substantial output intact. PMID31456285 B/C loss removes global Polycomb deposition while retaining most early repression; PMID35584662 restricts interpretation to parallel and partial contributions. Additional downgrade: False.

Spatial continuous-coat inference fails quantitative testing. PMIDs 34813726, 35301492, 26195790 show sparse RNA and amplified protein action. Finite imaging cannot exclude every undetected RNA. Additional downgrade: False.

Binding treated as regulation. RepA EMSA and UV-RIP contact cannot independently identify a necessary continuous scaffold.

Puncta and mark enrichment treated as mechanism. Low-resolution Xist clouds and H3K27me3 do not establish simultaneous chromosome-wide tethering.

A simplified rival is overclaimed. A pure serial SPEN-to-PRC cascade is revised by PMID35584662; a categorical no-direct-PRC2-contact conclusion conflicts with PMID38759625.

### Adversarial steelman: above, then below

One-rung-higher Δ steelman: rG4 mutants are native, preserve expression and change repression, while binding assays show direct PRC2 contact. This establishes a regulatory RNA-contact contribution, but the mutations preserve contact and do not isolate continuous structural tethering of both complexes. The registered SC2 mechanism therefore lacks its positive Δ crossing.

One-rung-lower Β steelman: promiscuous binding and sparse foci make the scaffold only descriptive. Direct biochemical and UV-supported contacts plus functional RNA-structure perturbations provide genuine mechanistic support, so Γ remains more informative for SC2 despite rejecting its complete conjunction.

Retain Γ: neither a narrower dynamic-contact success nor rejection of uniform coating can substitute for the registered dual-PRC scaffold.

### Final score, causal direction and M/S/D

The preregistered primary-subclaim rule uses SC2, giving Γ for direct continuous Polycomb scaffolding. SC1 is Η within initiation-competent mammalian contexts, while SC3 is Γ and SC4 Β for their stronger mechanism claims. Weakest-link sensitivity is Β. Evidence for Xist necessity and modular Polycomb causality is retained and cannot replace the nominal structural claim.

Step 1 does not establish that silencing produces a continuous dual-PRC RNA tether. At step 2, the proposed continuous scaffold has no isolated causal dependency in either direction, so the framework labels that descriptive structural claim epiphenomenon. This assignment explicitly does not apply to Xist itself, whose initiating causal role is strongly supported, or to the causal Polycomb effector arm.

Momentum: Mechanistic only. Lee 2024 tests rG4 regulation and Trotman 2025 tests adapter recruitment; Wei 2025 tests RNA turnover. No verified ongoing experiment isolates the registered continuous dual-PRC tether.

Stability: Stable. No named pending result is asserted to be likely to move the registered score imminently.

Divergence: Contested; no single implied-level arithmetic. These dimensions do not change level or confidence.

## PROPOSED DECISIVE EXPERIMENTS

At native female Xist expression, selectively disrupt a mapped direct RNA interface for each PRC while preserving SPEN, hnRNPK, RNA abundance and localization; compare initiation with expression-matched interface rescue and acute nascent allele-specific transcription.

Readout: RNA occupancy, UV-supported contact, PRC catalytic marks and gene-resolved nascent repression measured separately over initiation. Controls: Adapter-binding, RNA-processing, cell-cycle, global transcription and viability controls; wild-type and binding-deficient matched rescue; independent mammalian lineage. Supporting: Loss of only the direct tether prevents initiation and native matched rescue restores both contact and repression across defined genes. Falsifying: Silencing persists without the direct tether, or rescue restores contact without repression while adapter/effector pathways explain the output.

## RESEARCH TIMELINE

| Year | Milestone | Primary source | Interpretation |
|---|---|---|---|
| 1991 | Xi-associated Xist locus | [PMID2034279](https://pubmed.ncbi.nlm.nih.gov/2034279/) | Discovery association, before causal gene targeting |
| 1996 | Native Xist requirement | [PMID8538762](https://pubmed.ncbi.nlm.nih.gov/8538762/) | Initiating RNA necessity |
| 1997 | Dosage and parent-of-origin controls | [PMID9009199](https://pubmed.ncbi.nlm.nih.gov/9009199/) | Causal physiological scope |
| 2000 | Timed cis induction | [PMID10882105](https://pubmed.ncbi.nlm.nih.gov/10882105/) | Developmental competence and maintenance boundary |
| 2002 | Localization separated from silencing | [PMID11780141](https://pubmed.ncbi.nlm.nih.gov/11780141/) | Coating is insufficient |
| 2008 | RepA-PRC2 proposal | [PMID18974356](https://pubmed.ncbi.nlm.nih.gov/18974356/) | Direct affinity with RNA-expression confounding |
| 2015 | Direct SPEN pathway | [PMID25915022](https://pubmed.ncbi.nlm.nih.gov/25915022/) | Effector identity and functional output |
| 2017 | PCGF3/5 cascade | [PMID28596365](https://pubmed.ncbi.nlm.nih.gov/28596365/) | PRC1-first recruitment |
| 2017 | hnRNPK bridge and rescue | [PMID29220657](https://pubmed.ncbi.nlm.nih.gov/29220657/) | Adapter-mediated recruitment |
| 2019 | B/C loss retains early repression | [PMID31456285](https://pubmed.ncbi.nlm.nih.gov/31456285/) | Necessity is scoped |
| 2021 | Sparse foci and protein gradients | [PMID34813726](https://pubmed.ncbi.nlm.nih.gov/34813726/) | Continuous-coat inference challenged |
| 2022 | Parallel effector functions | [PMID35584662](https://pubmed.ncbi.nlm.nih.gov/35584662/) | SPEN/Polycomb separation of function |
| 2024 | rG4 regulates contact and release | [PMID38759625](https://pubmed.ncbi.nlm.nih.gov/38759625/) | Direct contact retained without permanent scaffold |
| 2025 | Isogenic Airn/Xist comparison | [PMID40118040](https://pubmed.ncbi.nlm.nih.gov/40118040/) | Marks and repression uncoupled |
| 2025 | Acute m6A loss accelerates XCI | [PMID40926104](https://pubmed.ncbi.nlm.nih.gov/40926104/) | Turnover revises knockdown interpretation |

## KNOWLEDGE GAPS

The frequency and functional necessity of direct PRC2 contact differ across UV-RIP and formaldehyde-RIP platforms; reconcile methods in isogenic lineages.

Map human and mouse domain functions under native expression rather than inferring species differences solely from ectopic cancer cells.

Separate catalytic release from continuous occupancy using RNA-interface lesions that preserve RNA localization and effector recruitment.

Determine quantitative RNA coverage with labeling-efficiency and false-negative controls across cell cycles.

Establish gene-class-specific initiation and maintenance requirements using acute interventions before chromosome-loss selection.

Resolve m6A loss timing, turnover and transcript-wide confounding in independently replicated native systems.

Audit the linked Markaki and G-tract correction bodies before a publication-grade whole-paper claim.

Measure model predictions prospectively; provider gap-grid empty cells are retrieval limitations, not proven absent research.

## METHODS AND CONSENSUS CONTRIBUTION

Consensus was used through the signed-in browser for discovery, counterevidence, research-gap and timeline suggestions, and attempted checks of specific indexed full-text passages. Provider statements about Methods/Results and any returned passages were compared with original-paper passages where available; failed retrievals, source substitutions and unverified aspects are recorded in the case reconciliation. Successful original-passage comparisons are distinguished from provider summaries and assertions of access. Provider screening counts, citation counts and meters were not used as primary counts or HSEF scores. This source log records access depth; it does not claim complete-paper or supplement review. The monthly API allowance was conserved: zero Consensus API calls in this batch.

## REVIEWER NOTES

65 peer-reviewed primary reports were examined at full abstract/status depth, with nine selected original-body examinations. No preprint duplicates, reviews, protocols or correction notices enter this count. Consensus contributed five canonical additional primary leads and targeted source-aspect comparisons; its categorical direct-contact statement and mistaken Lee-to-Colognori attribution were rejected. Correction metadata remains linked but correction bodies and complete supplements were not audited.

Search leads, reviews, protocols and correction notices do not pad the primary count. Downloaded XML does not earn examination credit. Linked notices remain attached; unexamined correction details limit inference. This is a coordinator source/claim consistency assessment, not independent blinded calibration.

## ADVERSARIAL REVIEW AND APPROVAL

**Authoring model:** Sol 6.1. **Adversarial reviewer:** Claude Opus 5.5 (Anthropic). **Date:** 2026-10-14.

**Scope of checks.** All 65 reference PMIDs verified against PubMed (65/65 resolve to the stated title, first author, journal and year; no retractions or expressions of concern; no empty DOI fields; no dropped collective authors). All 15 research-timeline years checked against the cited records. Ten load-bearing claims spot-checked against source abstracts (PMID 34813726, 31456285, 35584662, 38759625, 40118040, 29220657, 28596365, 40926104, 38181737, 18974356). Scoring logic re-derived against `hsef-hypothesis-review-v5/SKILL.md` Step 3 and `references/hsef-framework.md` (caps, primary-subclaim aggregation, role derivation, confidence band, momentum artifact). No level or confidence change.

| ID | Severity | Location | Original → corrected | Evidence |
|---|---|---|---|---|
| X-1 | Major | Evidence and causal interpretation (rG4 / Airn comparison paragraph); evidence card [61] | "native trophoblast formaldehyde-RIP in a 2025 Airn/Xist comparison" and "a different lineage" → the comparison is identified as formaldehyde-RIP on **ectopically expressed transgenes in mouse embryonic stem cells**, the same cell system as the rG4 work, with the separator restated as assay chemistry and construct context rather than lineage | PMID 40118040 (Trotman et al., *Mol Cell* 2025): the study expressed Airn and Xist "from an ectopic locus in mouse stem cells"; the indexed MeSH term is "Mouse Embryonic Stem Cells" and no trophoblast system appears. The comparator rG4 study (PMID 38759625) also uses mouse embryonic stem cells, so the asserted lineage difference did not exist. The misstatement was load-bearing: it was the stated reason the two platforms' opposite conclusions on direct PRC2 contact could coexist. |
| X-2 | Major | Consensus provenance reconciliation (9 October 2026) | "The earlier adversarial approval refers to its original edition" → "No earlier adversarial approval exists for this case" | No adversarial approval section, banner or approval line exists in any edition of this case, including the pre-revision copy in `hsef_v53_popularity_ranks_46_50_2026-10-09`. The sentence asserted an approval that was never issued. Introduced by the 9 October revision — a regression relative to the earlier edition. |
| X-3 | Minor | `final_score.confidence_rationale` (scorecard, 3 occurrences) | "density, heterogeneous controls and incomplete access set the confidence" → rationale restated in terms of evidence density and reproducibility, with access depth explicitly excluded | Framework: "Confidence reflects evidence density and reproducibility." Lead policy on confidence bands (2026-10-14): access depth is never a valid determinant. Re-derived band after striking it: the review documents substantive reproducibility concerns (platform-dependent contradictions on direct PRC2 contact, labelling-efficiency assumptions in the quantitative imaging, ectopic cancer-cell systems for the human domain work, unaudited correction bodies), so **Moderate stands**. |
| X-4 | Editorial | Falsification and pitfalls | "PMIDs34813726,35301492,26195790" → "PMIDs 34813726, 35301492, 26195790" | Glued-numeral rendering defect; all three PMIDs verified and unchanged. |

**Rejected findings (checked, no change).**
1. **Causal role "epiphenomenon".** This looked wrong against SC1 Η and the review's own statement that Polycomb has causal contributions. On re-derivation it is correct and explicitly scoped: the role attaches to the *registered* mechanism — a continuous direct dual-PRC tether — for which no causal dependency has been isolated in either direction (framework step 2), and the review states in terms that the assignment "does not apply to Xist itself … or to the causal Polycomb effector arm". A defensible judgement call under the framework text; not changed.
2. **Headline Γ and the primary-subclaim rule.** SC2 is named as the primary subclaim before scoring, the alternatives are reported (weakest-link Β, scope-matched Γ), and SC1 Η is correctly reported separately rather than raising the headline. The derivation wording matches the arithmetic. No change.
3. **"Best-supported rival" renderer artifact.** Checked the tournament ordering: rank 1 is "Modular effector pathways with a PRC1-first Polycomb cascade", which is not this review's nominal model (the nominal "Direct continuous Polycomb smart scaffold" ranks 5). The prose is correct as written.
4. **Momentum "Mechanistic only".** The required artifact names specific work (rG4 regulation, adapter recruitment, RNA turnover) and the review states no verified ongoing experiment isolates the registered tether. Per lead policy, the completed publications named could not have supported "Decisive work underway"; the review does not claim it.
5. **REVIEWER NOTES versus the spliced Consensus section.** The notes record a positive Consensus contribution (five additional primary leads, targeted source-aspect comparisons, two rejected provider assertions), consistent with the provenance section and the METHODS statement; there is no "no Consensus work was performed" claim to reconcile. No change.
6. **Zhao RepA attribution.** The review's statement that RepA depletion abolishes full-length Xist induction, and that this confounds attribution of silencing failure to an isolated PRC2 tether, matches PMID 18974356 exactly. No change.

**Residual limitations.** Nine of 65 sources had partial-body examination; the rest rest on abstracts and linked-status metadata, so body-level details asserted from original Results (for example the KI-domain mapping in PMID 29220657 and the acute-degradation controls in PMID 35584662) could not be independently reconfirmed here. The Markaki and G-tract correction bodies remain unaudited, as the review states. The package has no `lay_summary`, so the validator fails that v5.4 check — a pre-existing gap, not introduced by this pass. This pass is a source, claim and scoring-logic audit, not a blinded recalibration.

**Approval:** Following adversarial review and the corrections listed above, the revised document is approved. — Claude Opus 5.5 (Anthropic), 2026-10-14.

## REFERENCES

1. Dror I, Chitiashvili T, Tan SYX et al. XIST directly regulates X-linked and autosomal genes in naive human pluripotent cells. Cell. 2024. [PMID 38181737](https://pubmed.ncbi.nlm.nih.gov/38181737/). DOI: 10.1016/j.cell.2023.11.033. Access: abstract_metadata. Study: PMID38181737.

2. Chu C, Zhang QC, da Rocha ST et al. Systematic discovery of Xist RNA binding proteins. Cell. 2015. [PMID 25843628](https://pubmed.ncbi.nlm.nih.gov/25843628/). DOI: 10.1016/j.cell.2015.03.025. Access: abstract_metadata. Study: PMID25843628.

3. McHugh CA, Chen CK, Chow A et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015. [PMID 25915022](https://pubmed.ncbi.nlm.nih.gov/25915022/). DOI: 10.1038/nature14443. Access: abstract_metadata. Study: PMID25915022.

4. Betancur JG, Tomari Y. Cryptic RNA-binding by PRC2 components EZH2 and SUZ12. RNA biology. 2015. [PMID 26177152](https://pubmed.ncbi.nlm.nih.gov/26177152/). DOI: 10.1080/15476286.2015.1069463. Access: abstract_metadata. Study: PMID26177152.

5. Carter AC, Xu J, Nakamoto MY et al. Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation. eLife. 2020. [PMID 32379046](https://pubmed.ncbi.nlm.nih.gov/32379046/). DOI: 10.7554/eLife.54508. Access: abstract_metadata. Study: PMID32379046.

6. Barros de Andrade E Sousa L, Jonkers I, Syx L et al. Kinetics of Xist-induced gene silencing can be predicted from combinations of epigenetic and genomic features. Genome research. 2019. [PMID 31175153](https://pubmed.ncbi.nlm.nih.gov/31175153/). DOI: 10.1101/gr.245027.118. Access: abstract_metadata. Study: PMID31175153.

7. Plath K, Fang J, Mlynarczyk-Evans SK et al. Role of histone H3 lysine 27 methylation in X inactivation. Science (New York, N.Y.). 2003. [PMID 12649488](https://pubmed.ncbi.nlm.nih.gov/12649488/). DOI: 10.1126/science.1084274. Access: abstract_metadata. Study: PMID12649488.

8. Markaki Y, Gan Chong J, Wang Y et al. Xist nucleates local protein gradients to propagate silencing across the X chromosome. Cell. 2021. [PMID 34813726](https://pubmed.ncbi.nlm.nih.gov/34813726/). DOI: 10.1016/j.cell.2021.10.022. Access: full_text_partial. Study: PMID34813726.

9. Schertzer MD, Braceros KCA, Starmer J et al. lncRNA-Induced Spread of Polycomb Controlled by Genome Architecture, RNA Abundance, and CpG Island DNA. Molecular cell. 2019. [PMID 31256989](https://pubmed.ncbi.nlm.nih.gov/31256989/). DOI: 10.1016/j.molcel.2019.05.028. Access: abstract_metadata. Study: PMID31256989.

10. Gilbert SL, Pehrson JR, Sharp PA. XIST RNA associates with specific regions of the inactive X chromatin. The Journal of biological chemistry. 2000. [PMID 11006266](https://pubmed.ncbi.nlm.nih.gov/11006266/). DOI: 10.1074/jbc.C000409200. Access: abstract_metadata. Study: PMID11006266.

11. Westervelt N, Yoest A, Sayed S et al. Deletion of the XIST promoter from the human inactive X chromosome compromises polycomb heterochromatin maintenance. Chromosoma. 2021. [PMID 33745031](https://pubmed.ncbi.nlm.nih.gov/33745031/). DOI: 10.1007/s00412-021-00754-z. Access: abstract_metadata. Study: PMID33745031.

12. Almeida M, Pintacuda G, Masui O et al. PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation. Science (New York, N.Y.). 2017. [PMID 28596365](https://pubmed.ncbi.nlm.nih.gov/28596365/). DOI: 10.1126/science.aal2512. Access: full_text_partial. Study: Oxford-PCGF-Xist-platform.

13. Żylicz JJ, Bousard A, Žumer K et al. The Implication of Early Chromatin Changes in X Chromosome Inactivation. Cell. 2019. [PMID 30595450](https://pubmed.ncbi.nlm.nih.gov/30595450/). DOI: 10.1016/j.cell.2018.11.041. Access: abstract_metadata. Study: PMID30595450.

14. Dossin F, Pinheiro I, Żylicz JJ et al. SPEN integrates transcriptional and epigenetic control of X-inactivation. Nature. 2020. [PMID 32025035](https://pubmed.ncbi.nlm.nih.gov/32025035/). DOI: 10.1038/s41586-020-1974-9. Access: abstract_metadata. Study: PMID32025035.

15. Kalantry S, Mills KC, Yee D et al. The Polycomb group protein Eed protects the inactive X-chromosome from differentiation-induced reactivation. Nature cell biology. 2006. [PMID 16415857](https://pubmed.ncbi.nlm.nih.gov/16415857/). DOI: 10.1038/ncb1351. Access: abstract_metadata. Study: PMID16415857.

16. Robert-Finestra T, Tan BF, Mira-Bontenbal H et al. SPEN is required for Xist upregulation during initiation of X chromosome inactivation. Nature communications. 2021. [PMID 34853312](https://pubmed.ncbi.nlm.nih.gov/34853312/). DOI: 10.1038/s41467-021-27294-5. Access: abstract_metadata. Study: PMID34853312.

17. Du Z, Hu L, Zou Z et al. Stepwise de novo establishment of inactive X chromosome architecture in early development. Nature genetics. 2024. [PMID 39256583](https://pubmed.ncbi.nlm.nih.gov/39256583/). DOI: 10.1038/s41588-024-01897-2. Access: abstract_metadata. Study: PMID39256583.

18. Lee HJ, Gopalappa R, Sunwoo H et al. En bloc and segmental deletions of human XIST reveal X chromosome inactivation-involving RNA elements. Nucleic acids research. 2019. [PMID 30783652](https://pubmed.ncbi.nlm.nih.gov/30783652/). DOI: 10.1093/nar/gkz109. Access: abstract_metadata. Study: PMID30783652.

19. Collombet S, Rall I, Dugast-Darzacq C et al. RNA polymerase II depletion from the inactive X chromosome territory is not mediated by physical compartmentalization. Nature structural & molecular biology. 2023. [PMID 37291424](https://pubmed.ncbi.nlm.nih.gov/37291424/). DOI: 10.1038/s41594-023-01008-5. Access: abstract_metadata. Study: PMID37291424.

20. Hoki Y, Ikeda R, Mise N et al. Incomplete X-inactivation initiated by a hypomorphic Xist allele in the mouse. Development (Cambridge, England). 2011. [PMID 21613321](https://pubmed.ncbi.nlm.nih.gov/21613321/). DOI: 10.1242/dev.061226. Access: abstract_metadata. Study: PMID21613321.

21. Jansz N, Nesterova T, Keniry A et al. Smchd1 Targeting to the Inactive X Is Dependent on the Xist-HnrnpK-PRC1 Pathway. Cell reports. 2018. [PMID 30428357](https://pubmed.ncbi.nlm.nih.gov/30428357/). DOI: 10.1016/j.celrep.2018.10.044. Access: abstract_metadata. Study: PMID30428357.

22. Brockdorff N, Ashworth A, Kay GF et al. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell. 1992. [PMID 1423610](https://pubmed.ncbi.nlm.nih.gov/1423610/). DOI: 10.1016/0092-8674(92)90519-i. Access: abstract_metadata. Study: PMID1423610.

23. Engreitz JM, Pandya-Jones A, McDonel P et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science (New York, N.Y.). 2013. [PMID 23828888](https://pubmed.ncbi.nlm.nih.gov/23828888/). DOI: 10.1126/science.1237973. Access: abstract_metadata. Study: PMID23828888.

24. Gayen S, Maclary E, Hinten M et al. Sex-specific silencing of X-linked genes by Xist RNA. Proceedings of the National Academy of Sciences of the United States of America. 2016. [PMID 26739568](https://pubmed.ncbi.nlm.nih.gov/26739568/). DOI: 10.1073/pnas.1515971113. Access: abstract_metadata. Study: PMID26739568.

25. Royce-Tolland ME, Andersen AA, Koyfman HR et al. The A-repeat links ASF/SF2-dependent Xist RNA processing with random choice during X inactivation. Nature structural & molecular biology. 2010. [PMID 20657585](https://pubmed.ncbi.nlm.nih.gov/20657585/). DOI: 10.1038/nsmb.1877. Access: abstract_metadata. Study: PMID20657585.

26. Tjalsma SJD, Hori M, Sato Y et al. H4K20me1 and H3K27me3 are concurrently loaded onto the inactive X chromosome but dispensable for inducing gene silencing. EMBO reports. 2021. [PMID 33605056](https://pubmed.ncbi.nlm.nih.gov/33605056/). DOI: 10.15252/embr.202051989. Access: abstract_metadata. Study: PMID33605056.

27. Pintacuda G, Wei G, Roustan C et al. hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing. Molecular cell. 2017. [PMID 29220657](https://pubmed.ncbi.nlm.nih.gov/29220657/). DOI: 10.1016/j.molcel.2017.11.013. Access: full_text_partial. Study: Oxford-PCGF-Xist-platform.

28. Lu Z, Guo JK, Wei Y et al. Structural modularity of the XIST ribonucleoprotein complex. Nature communications. 2020. [PMID 33268787](https://pubmed.ncbi.nlm.nih.gov/33268787/). DOI: 10.1038/s41467-020-20040-3. Access: abstract_metadata. Study: PMID33268787.

29. Bousard A, Raposo AC, Żylicz JJ et al. The role of Xist-mediated Polycomb recruitment in the initiation of X-chromosome inactivation. EMBO reports. 2019. [PMID 31456285](https://pubmed.ncbi.nlm.nih.gov/31456285/). DOI: 10.15252/embr.201948019. Access: full_text_partial. Study: PMID31456285.

30. Ridings-Figueroa R, Stewart ER, Nesterova TB et al. The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory. Genes & development. 2017. [PMID 28546514](https://pubmed.ncbi.nlm.nih.gov/28546514/). DOI: 10.1101/gad.295907.117. Access: abstract_metadata. Study: PMID28546514.

31. Kriz AJ, Colognori D, Sunwoo H et al. Balancing cohesin eviction and retention prevents aberrant chromosomal interactions, Polycomb-mediated repression, and X-inactivation. Molecular cell. 2021. [PMID 33725485](https://pubmed.ncbi.nlm.nih.gov/33725485/). DOI: 10.1016/j.molcel.2021.02.031. Access: abstract_metadata. Study: PMID33725485.

32. Sunwoo H, Colognori D, Froberg JE et al. Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1). Proceedings of the National Academy of Sciences of the United States of America. 2017. [PMID 28923964](https://pubmed.ncbi.nlm.nih.gov/28923964/). DOI: 10.1073/pnas.1711206114. Access: abstract_metadata. Study: PMID28923964.

33. Minajigi A, Froberg J, Wei C et al. Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. Science (New York, N.Y.). 2015. [PMID 26089354](https://pubmed.ncbi.nlm.nih.gov/26089354/). DOI: 10.1126/science.aab2276. Access: abstract_metadata. Study: PMID26089354.

34. Wang CY, Jégu T, Chu HP et al. SMCHD1 Merges Chromosome Compartments and Assists Formation of Super-Structures on the Inactive X. Cell. 2018. [PMID 29887375](https://pubmed.ncbi.nlm.nih.gov/29887375/). DOI: 10.1016/j.cell.2018.05.007. Access: abstract_metadata. Study: PMID29887375.

35. Moindrot B, Cerase A, Coker H et al. A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing. Cell reports. 2015. [PMID 26190105](https://pubmed.ncbi.nlm.nih.gov/26190105/). DOI: 10.1016/j.celrep.2015.06.053. Access: abstract_metadata. Study: PMID26190105.

36. Nakamoto MY, Lammer NC, Batey RT et al. hnRNPK recognition of the B motif of Xist and other biological RNAs. Nucleic acids research. 2020. [PMID 32813011](https://pubmed.ncbi.nlm.nih.gov/32813011/). DOI: 10.1093/nar/gkaa677. Access: abstract_metadata. Study: PMID32813011.

37. Patil DP, Chen CK, Pickering BF et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016. [PMID 27602518](https://pubmed.ncbi.nlm.nih.gov/27602518/). DOI: 10.1038/nature19342. Access: abstract_metadata. Study: PMID27602518.

38. Yu B, Qi Y, Li R et al. B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells. Cell. 2021. [PMID 33735607](https://pubmed.ncbi.nlm.nih.gov/33735607/). DOI: 10.1016/j.cell.2021.02.015. Access: abstract_metadata. Study: PMID33735607.

39. Marahrens Y, Panning B, Dausman J et al. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes & development. 1997. [PMID 9009199](https://pubmed.ncbi.nlm.nih.gov/9009199/). DOI: 10.1101/gad.11.2.156. Access: abstract_metadata. Study: PMID9009199.

40. Kay GF, Penny GD, Patel D et al. Expression of Xist during mouse development suggests a role in the initiation of X chromosome inactivation. Cell. 1993. [PMID 8425217](https://pubmed.ncbi.nlm.nih.gov/8425217/). DOI: 10.1016/0092-8674(93)90658-d. Access: abstract_metadata. Study: PMID8425217.

41. Brockdorff N, Ashworth A, Kay GF et al. Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature. 1991. [PMID 2034279](https://pubmed.ncbi.nlm.nih.gov/2034279/). DOI: 10.1038/351329a0. Access: abstract_metadata. Study: PMID2034279.

42. Wutz A, Jaenisch R. A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Molecular cell. 2000. [PMID 10882105](https://pubmed.ncbi.nlm.nih.gov/10882105/). DOI: 10.1016/s1097-2765(00)80248-8. Access: abstract_metadata. Study: PMID10882105.

43. Wutz A, Rasmussen TP, Jaenisch R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nature genetics. 2002. [PMID 11780141](https://pubmed.ncbi.nlm.nih.gov/11780141/). DOI: 10.1038/ng820. Access: abstract_metadata. Study: PMID11780141.

44. Penny GD, Kay GF, Sheardown SA et al. Requirement for Xist in X chromosome inactivation. Nature. 1996. [PMID 8538762](https://pubmed.ncbi.nlm.nih.gov/8538762/). DOI: 10.1038/379131a0. Access: abstract_metadata. Study: PMID8538762.

45. Bowness JS, Nesterova TB, Wei G et al. Xist-mediated silencing requires additive functions of SPEN and Polycomb together with differentiation-dependent recruitment of SmcHD1. Cell reports. 2022. [PMID 35584662](https://pubmed.ncbi.nlm.nih.gov/35584662/). DOI: 10.1016/j.celrep.2022.110830. Access: full_text_partial. Study: Oxford-allelic-Xist-platform.

46. Wei G, Coker H, Rodermund L et al. m6A and the NEXT complex direct Xist RNA turnover and X-inactivation dynamics. Nature structural & molecular biology. 2025. [PMID 40926104](https://pubmed.ncbi.nlm.nih.gov/40926104/). DOI: 10.1038/s41594-025-01663-w. Access: abstract_metadata. Study: PMID40926104.

47. Jachowicz JW, Strehle M, Banerjee AK et al. Xist spatially amplifies SHARP/SPEN recruitment to balance chromosome-wide silencing and specificity to the X chromosome. Nature structural & molecular biology. 2022. [PMID 35301492](https://pubmed.ncbi.nlm.nih.gov/35301492/). DOI: 10.1038/s41594-022-00739-1. Access: abstract_metadata. Study: PMID35301492.

48. Wang Y, Zhong Y, Zhou Y et al. Identification of a Xist silencing domain by Tiling CRISPR. Scientific reports. 2019. [PMID 30787302](https://pubmed.ncbi.nlm.nih.gov/30787302/). DOI: 10.1038/s41598-018-36750-0. Access: abstract_metadata. Study: PMID30787302.

49. Rodermund L, Coker H, Oldenkamp R et al. Time-resolved structured illumination microscopy reveals key principles of Xist RNA spreading. Science (New York, N.Y.). 2021. [PMID 34112668](https://pubmed.ncbi.nlm.nih.gov/34112668/). DOI: 10.1126/science.abe7500. Access: abstract_metadata. Study: Oxford-allelic-Xist-platform.

50. Beltran M, Tavares M, Justin N et al. G-tract RNA removes Polycomb repressive complex 2 from genes. Nature structural & molecular biology. 2019. [PMID 31548724](https://pubmed.ncbi.nlm.nih.gov/31548724/). DOI: 10.1038/s41594-019-0293-z. Access: abstract_metadata. Study: PMID31548724.

51. Wang X, Goodrich KJ, Gooding AR et al. Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines. Molecular cell. 2017. [PMID 28306504](https://pubmed.ncbi.nlm.nih.gov/28306504/). DOI: 10.1016/j.molcel.2017.02.003. Access: abstract_metadata. Study: PMID28306504.

52. Davidovich C, Zheng L, Goodrich KJ et al. Promiscuous RNA binding by Polycomb repressive complex 2. Nature structural & molecular biology. 2013. [PMID 24077223](https://pubmed.ncbi.nlm.nih.gov/24077223/). DOI: 10.1038/nsmb.2679. Access: abstract_metadata. Study: PMID24077223.

53. Beltran M, Yates CM, Skalska L et al. The interaction of PRC2 with RNA or chromatin is mutually antagonistic. Genome research. 2016. [PMID 27197219](https://pubmed.ncbi.nlm.nih.gov/27197219/). DOI: 10.1101/gr.197632.115. Access: abstract_metadata. Study: PMID27197219.

54. Davidovich C, Wang X, Cifuentes-Rojas C et al. Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA. Molecular cell. 2015. [PMID 25601759](https://pubmed.ncbi.nlm.nih.gov/25601759/). DOI: 10.1016/j.molcel.2014.12.017. Access: abstract_metadata. Study: PMID25601759.

55. Healy E, Zhang Q, Gail EH et al. The apparent loss of PRC2 chromatin occupancy as an artifact of RNA depletion. Cell reports. 2024. [PMID 38416645](https://pubmed.ncbi.nlm.nih.gov/38416645/). DOI: 10.1016/j.celrep.2024.113858. Access: abstract_metadata. Study: PMID38416645.

56. Long Y, Bolanos B, Gong L et al. Conserved RNA-binding specificity of polycomb repressive complex 2 is achieved by dispersed amino acid patches in EZH2. eLife. 2017. [PMID 29185984](https://pubmed.ncbi.nlm.nih.gov/29185984/). DOI: 10.7554/eLife.31558. Access: abstract_metadata. Study: PMID29185984.

57. Wang X, Paucek RD, Gooding AR et al. Molecular analysis of PRC2 recruitment to DNA in chromatin and its inhibition by RNA. Nature structural & molecular biology. 2017. [PMID 29058709](https://pubmed.ncbi.nlm.nih.gov/29058709/). DOI: 10.1038/nsmb.3487. Access: abstract_metadata. Study: PMID29058709.

58. Zhao J, Sun BK, Erwin JA et al. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science (New York, N.Y.). 2008. [PMID 18974356](https://pubmed.ncbi.nlm.nih.gov/18974356/). DOI: 10.1126/science.1163045. Access: full_text_partial. Study: PMID18974356.

59. Schoeftner S, Sengupta AK, Kubicek S et al. Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing. The EMBO journal. 2006. [PMID 16763550](https://pubmed.ncbi.nlm.nih.gov/16763550/). DOI: 10.1038/sj.emboj.7601187. Access: abstract_metadata. Study: PMID16763550.

60. Dixon-McDougall T, Brown CJ. Independent domains for recruitment of PRC1 and PRC2 by human XIST. PLoS genetics. 2021. [PMID 33750950](https://pubmed.ncbi.nlm.nih.gov/33750950/). DOI: 10.1371/journal.pgen.1009123. Access: full_text_partial. Study: PMID33750950.

61. Trotman JB, Abrash EW, Murvin MM et al. Isogenic comparison of Airn and Xist reveals core principles of Polycomb recruitment by lncRNAs. Molecular cell. 2025. [PMID 40118040](https://pubmed.ncbi.nlm.nih.gov/40118040/). DOI: 10.1016/j.molcel.2025.02.014. Access: full_text_partial. Study: PMID40118040.

62. Lee YW, Weissbein U, Blum R et al. G-quadruplex folding in Xist RNA antagonizes PRC2 activity for stepwise regulation of X chromosome inactivation. Molecular cell. 2024. [PMID 38759625](https://pubmed.ncbi.nlm.nih.gov/38759625/). DOI: 10.1016/j.molcel.2024.04.015. Access: full_text_partial. Study: Lee-Xist-rG4-platform.

63. Sunwoo H, Wu JY, Lee JT. The Xist RNA-PRC2 complex at 20-nm resolution reveals a low Xist stoichiometry and suggests a hit-and-run mechanism in mouse cells. Proceedings of the National Academy of Sciences of the United States of America. 2015. [PMID 26195790](https://pubmed.ncbi.nlm.nih.gov/26195790/). DOI: 10.1073/pnas.1503690112. Access: abstract_metadata. Study: Lee-Xist-spatial-platform.

64. Nesterova TB, Wei G, Coker H et al. Systematic allelic analysis defines the interplay of key pathways in X chromosome inactivation. Nature communications. 2019. [PMID 31311937](https://pubmed.ncbi.nlm.nih.gov/31311937/). DOI: 10.1038/s41467-019-11171-3. Access: abstract_metadata. Study: Oxford-allelic-Xist-platform.

65. Colognori D, Sunwoo H, Kriz AJ et al. Xist Deletional Analysis Reveals an Interdependency between Xist RNA and Polycomb Complexes for Spreading along the Inactive X. Molecular cell. 2019. [PMID 30827740](https://pubmed.ncbi.nlm.nih.gov/30827740/). DOI: 10.1016/j.molcel.2019.01.015. Access: abstract_metadata. Study: Lee-Xist-deletion-platform.

## Source-specific evidence cards

### [1] XIST directly regulates X-linked and autosomal genes in naive human pluripotent cells.

**Shows:** XIST perturbation supports X-linked dampening and some autosomal targeting in naive cells.

**Does not show:** Dampening and dispersed localization differ from complete cis silencing; no continuous Polycomb scaffold is isolated.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC4.

### [2] Systematic discovery of Xist RNA binding proteins.

**Shows:** Interactome and knockdowns identify modular SPEN and hnRNPK functions coupled to differentiation.

**Does not show:** Crosslinked association does not establish every interactor as a direct RNA binder or continuous tether.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [3] The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3.

**Shows:** Direct SHARP association and HDAC3/SMRT perturbation connect Xist to transcriptional repression and Pol II loss.

**Does not show:** PRC2 recruitment dependence on this pathway does not itself prove direct Xist-PRC2 contact or a single serial cascade.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [4] Cryptic RNA-binding by PRC2 components EZH2 and SUZ12.

**Shows:** EZH2 and SUZ12 bind RNA directly with length and substrate preferences.

**Does not show:** Biochemical binding is not native selective tethering of both Polycomb complexes.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [5] Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation.

**Shows:** An ERV element replaces A-repeat binding to SPEN and supports strictly local cis repression.

**Does not show:** Local rescue cannot establish full chromosome silencing or Polycomb as the initiating scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [6] Kinetics of Xist-induced gene silencing can be predicted from combinations of epigenetic and genomic features.

**Shows:** Repeat perturbations distinguish SPEN-dependent and pre-Polycomb-marked gene classes with different kinetics.

**Does not show:** Predictive genomic features remain correlates; classes do not imply universal Polycomb necessity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3.

### [7] Role of histone H3 lysine 27 methylation in X inactivation.

**Shows:** Xist-dependent EED/EZH2 and H3K27 methylation can occur independently of Xist silencing function.

**Does not show:** Recruitment and methylation are not sufficient for silencing; no continuous tether measured.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3.

### [8] Xist nucleates local protein gradients to propagate silencing across the X chromosome.

**Shows:** Calibrated sparse Xist foci nucleate many SPEN molecules; B-repeat loss impairs compaction and especially late silencing.

**Does not show:** Molecule estimates depend on labeling calibration; local assemblies and protein gradients are not a continuous RNA coat.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph2, 1:Results:paragraph3, 1:Results:paragraph4, 1:Results:paragraph11, 1:Results:paragraph12, 1:Results:paragraph17, 1:Results:paragraph18. No complete-paper or supplement audit claimed. ErratumIn: PMID34890555. Subclaims: SC2, SC3, SC4.

### [9] lncRNA-Induced Spread of Polycomb Controlled by Genome Architecture, RNA Abundance, and CpG Island DNA.

**Shows:** RNA abundance, architecture and autonomously Polycomb-binding CpG islands shape broad modification domains.

**Does not show:** Other lncRNAs and correlated domain patterns cannot alone identify the Xist recruitment mechanism.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [10] XIST RNA associates with specific regions of the inactive X chromatin.

**Shows:** XIST coprecipitates with macroH2A and hypoacetylated chromatin.

**Does not show:** Chromatin association can be indirect and does not resolve a uniform RNA-Polycomb tether.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [11] Deletion of the XIST promoter from the human inactive X chromosome compromises polycomb heterochromatin maintenance.

**Shows:** XIST promoter deletion reduces Polycomb marks without appreciable gene reactivation in the tested cells.

**Does not show:** Maintenance redundancy is lineage-specific; it does not erase XIST initiation necessity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [12] PCGF3/5-PRC1 initiates Polycomb recruitment in X chromosome inactivation.

**Shows:** PCGF3/5 double loss abolishes Xi Polycomb marks and compromises silencing; single-loss controls and embryos support a PRC1-first route.

**Does not show:** Global PCGF loss and transgenic induction are not a direct RNA interface-specific test; phenotype does not prove PRC2-first scaffolding.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Main text:paragraph9, 1:Main text:paragraph10, 1:Main text:paragraph11, 1:Main text:paragraph12. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [13] The Implication of Early Chromatin Changes in X Chromosome Inactivation.

**Shows:** HDAC3 activity and early deacetylation accompany silencing before Polycomb spreads into genes.

**Does not show:** Temporal order and HDAC3 perturbation do not require that all Polycomb activity lies downstream of SPEN.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3.

### [14] SPEN integrates transcriptional and epigenetic control of X-inactivation.

**Shows:** SPEN is required for embryonic initiation, disengages after silencing, and SPOC tethering supports repression.

**Does not show:** SPEN is dispensable for much neural maintenance; total SPEN loss also alters RNA localization and does not isolate its effector domain.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC3.

### [15] The Polycomb group protein Eed protects the inactive X-chromosome from differentiation-induced reactivation.

**Shows:** Silent Xi persists without EED in undifferentiated cells but reactivates upon differentiation.

**Does not show:** A differentiation-dependent memory role is not general Polycomb dispensability at initiation.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3.

### [16] SPEN is required for Xist upregulation during initiation of X chromosome inactivation.

**Shows:** SPEN loss impairs Xist upregulation and concomitant Tsix removal rescues that defect.

**Does not show:** Silencing failure after SPEN loss partly reflects altered Xist abundance rather than only downstream repression.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [17] Stepwise de novo establishment of inactive X chromosome architecture in early development.

**Shows:** Xist regulatory-region disruption and cohesin degradation link stage-specific megadomains to local regulation.

**Does not show:** Chromosome folding boundaries are not direct Polycomb tethers and may be strain-specific.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC4.

### [18] En bloc and segmental deletions of human XIST reveal X chromosome inactivation-involving RNA elements.

**Shows:** Whole XIST deletion reactivates genes; segmental deletion maps maintenance functions including exon 5.

**Does not show:** A cancer cell line and maintenance context cannot fix all human developmental domains or the direct PRC binding interface.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [19] RNA polymerase II depletion from the inactive X chromosome territory is not mediated by physical compartmentalization.

**Shows:** RNAPII can enter the Xist territory; apparent depletion reflects reduced chromatin-bound transcription machinery.

**Does not show:** Accessible diffusion does not exclude all local protein assemblies or every mature Xi physical effect.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [20] Incomplete X-inactivation initiated by a hypomorphic Xist allele in the mouse.

**Shows:** Mutant Xist coats the X yet establishes incomplete and unstable silencing.

**Does not show:** Coating is insufficient; the allele perturbs more than a selective Polycomb interface.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [21] Smchd1 Targeting to the Inactive X Is Dependent on the Xist-HnrnpK-PRC1 Pathway.

**Shows:** SMCHD1 recruitment depends on the Xist-hnRNPK-PRC1/H2AK119ub pathway and lacks specific RNA binding in assays.

**Does not show:** This supports indirect downstream recruitment rather than proving PRC2 never contacts Xist.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [22] The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus.

**Shows:** Xist is a conserved nuclear untranslated repeat-containing transcript expressed from Xi.

**Does not show:** Localization and sequence conservation are discovery evidence, not silencing causality or scaffold necessity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC4.

### [23] The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome.

**Shows:** Xist spreading exploits pre-existing 3D proximity and its silencing domain to access active regions.

**Does not show:** Population occupancy maps do not show simultaneous uniform coverage in individual cells.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [24] Sex-specific silencing of X-linked genes by Xist RNA.

**Shows:** Comparable Xist induction/coating yields sex- and X-dose-dependent differences in silencing.

**Does not show:** Coating alone is insufficient; ectopic Tsix-driven expression does not represent every normal initiation condition.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC4.

### [25] The A-repeat links ASF/SF2-dependent Xist RNA processing with random choice during X inactivation.

**Shows:** A-repeat regulates spliced Xist accumulation and random choice.

**Does not show:** A-repeat deletion has an RNA-processing confound and cannot be read solely as selective PRC2 binding loss.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [26] H4K20me1 and H3K27me3 are concurrently loaded onto the inactive X chromosome but dispensable for inducing gene silencing.

**Shows:** B/C-deficient Xist retains silencing despite loss of H3K27me3 and H4K20me1 accumulation.

**Does not show:** Retained initiation does not exclude stabilization or gene-specific Polycomb dependence.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4.

### [27] hnRNPK Recruits PCGF3/5-PRC1 to the Xist RNA B-Repeat to Establish Polycomb-Mediated Chromosomal Silencing.

**Shows:** hnRNPK directly bridges B-repeat to PCGF3-PRC1; KI-deficient and GFP tether controls fail while hnRNPK restores marks and silencing.

**Does not show:** Synthetic tethering is a mechanistic rescue within engineered cells, not proof of a direct continuous RNA interaction with both PRCs.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph44, 1:Results:paragraph49, 1:Results:paragraph50, 1:Results:paragraph51, 1:Results:paragraph60, 1:Results:paragraph61, 1:Results:paragraph62. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [28] Structural modularity of the XIST ribonucleoprotein complex.

**Shows:** Orthogonal RNA structure and interaction methods plus A-repeat relocation show modular RNP architecture.

**Does not show:** A structured modular RNA is not automatically a chromosome-wide Polycomb scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [29] The role of Xist-mediated Polycomb recruitment in the initiation of X-chromosome inactivation.

**Shows:** B/C loss removes PCGF3/5 association and global marks while most initial silencing persists; RNA stability/coating and A-repeat controls distinguish effects.

**Does not show:** Induced XY expression exceeds native maintenance signal and residual promoter marks remain; modest silencing deficits cannot be described as zero Polycomb function.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph0, 1:Results:paragraph15, 1:Results:paragraph26, 1:Results:paragraph28, 1:Results:paragraph42, 1:Results:paragraph52, 1:Results:paragraph63. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [30] The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory.

**Shows:** CIZ1 loss disperses Xist in somatic lineages and re-expression restores focal localization.

**Does not show:** Anchoring to a matrix is not direct binding of Xist to both PRCs; viable mutants restrict universality.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [31] Balancing cohesin eviction and retention prevents aberrant chromosomal interactions, Polycomb-mediated repression, and X-inactivation.

**Shows:** Cohesin loss greatly changes Xi structure with little repression change, whereas retention disrupts Xist spreading and silencing.

**Does not show:** Structure-function dependence is asymmetric and cannot be reduced to all structural perturbations causing transcription loss.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4.

### [32] Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1).

**Shows:** Repeat E/CIZ1 loss and CIZ1 overexpression disperse Xist with reduced H3K27me3.

**Does not show:** Dose-sensitive local anchoring does not establish continuous chromosome-wide RNA occupancy.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [33] Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation.

**Shows:** Broad Xist interactome and multi-factor inhibition reveal layered repression and cohesin eviction.

**Does not show:** Association/proteomic sensitivity and multi-target intervention do not identify a unique direct PRC scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4.

### [34] SMCHD1 Merges Chromosome Compartments and Assists Formation of Super-Structures on the Inactive X.

**Shows:** SMCHD1 loss preserves intermediate compartments, impairs regional Xist spread and silencing.

**Does not show:** Architectural contribution is downstream or cooperative, not continuous direct Xist-PRC tethering.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4.

### [35] A Pooled shRNA Screen Identifies Rbm15, Spen, and Wtap as Factors Required for Xist RNA-Mediated Silencing.

**Shows:** SPEN RBM15 and WTAP perturbations impair establishment and factors colocalize with Xist.

**Does not show:** shRNA and colocalization can involve RNA abundance or indirect effects; later acute m6A tests revise necessity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [36] hnRNPK recognition of the B motif of Xist and other biological RNAs.

**Shows:** Multiple hnRNPK domains and RNA conformation determine B-motif binding affinity.

**Does not show:** C-patch preference is not sufficient to predict every cellular binding site; isolated affinity does not establish continuous occupancy.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [37] m(6)A RNA methylation promotes XIST-mediated transcriptional repression.

**Shows:** m6A machinery knockdown impairs XIST repression and synthetic YTHDC1 tethering rescues it.

**Does not show:** Transcript-wide effects and engineered rescue do not establish native m6A necessity; acute METTL3 depletion produces a different result.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [38] B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells.

**Shows:** XIST continuously restrains a subset of immune genes through lineage-specific repression with TRIM28.

**Does not show:** B-cell maintenance differs from diploid somatic redundancy; continual XIST requirement is not a continuous Polycomb scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. UpdateOf: PMID33442682. Subclaims: SC1, SC3.

### [39] Xist-deficient mice are defective in dosage compensation but not spermatogenesis.

**Shows:** Parent-of-origin deletion gives dosage-compensation failure and female embryonic lethality; XO and male controls resolve dosage effects.

**Does not show:** These controls establish Xist function without distinguishing direct PRC tethering from modular recruitment.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [40] Expression of Xist during mouse development suggests a role in the initiation of X chromosome inactivation.

**Shows:** Xist expression precedes XCI and shows developmental imprinting.

**Does not show:** Temporal precedence without perturbation cannot establish necessary scaffold action.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [41] Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome.

**Shows:** Conserved locus and exclusive Xi expression identify a candidate dosage-compensation RNA.

**Does not show:** Mapping and association alone do not show causality.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [42] A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation.

**Shows:** Xist initiates long-range cis repression within a developmental window and later repression becomes less Xist-dependent.

**Does not show:** Ectopic sufficiency is context-limited; irreversible maintenance does not require continuous RNA scaffold persistence.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [43] Chromosomal silencing and localization are mediated by different domains of Xist RNA.

**Shows:** A-repeat loss preserves localization/spreading but abolishes silencing, separating functions.

**Does not show:** Engineered cDNA-domain behavior cannot alone identify native PRC recruitment interfaces.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3, SC4.

### [44] Requirement for Xist in X chromosome inactivation.

**Shows:** Xist gene targeting demonstrates requirement for normal XCI.

**Does not show:** The abstract is brief and gives no direct Polycomb-scaffold test; no complete body audit here.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1.

### [45] Xist-mediated silencing requires additive functions of SPEN and Polycomb together with differentiation-dependent recruitment of SmcHD1.

**Shows:** Parallel SPEN and Polycomb contributions are separated; combined loss abolishes repression with comparable Xist abundance and RNA-domain controls.

**Does not show:** Residual localization defects and chromosome-loss selection constrain late endpoints; Polycomb causality does not identify a continuous scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph0, 1:Results:paragraph18, 1:Results:paragraph19, 1:Results:paragraph20, 1:Results:paragraph21, 1:Results:paragraph26. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [46] m6A and the NEXT complex direct Xist RNA turnover and X-inactivation dynamics.

**Shows:** Acute m6A loss accelerates XCI with increased Xist stability; NEXT-mediated turnover is YTHDC1-independent.

**Does not show:** This revises m6A-necessity interpretation, not the need for Xist itself or all RNA modifications.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [47] Xist spatially amplifies SHARP/SPEN recruitment to balance chromosome-wide silencing and specificity to the X chromosome.

**Shows:** Non-stoichiometric SHARP amplification represses regions without direct Xist occupancy; increased RNA also spreads to autosomes.

**Does not show:** Protein self-assembly need not constitute phase separation or a uniform RNA coat; high expression changes specificity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [48] Identification of a Xist silencing domain by Tiling CRISPR.

**Shows:** A-repeat screening identifies silencing function and effects on Xist transcription.

**Does not show:** Regulatory DNA/RNA-production effects complicate reading deletions as isolated scaffold lesions.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3.

### [49] Time-resolved structured illumination microscopy reveals key principles of Xist RNA spreading.

**Shows:** Old and new RNA couple physically and SPEN affects localization stability and synthesis-degradation feedback.

**Does not show:** Tagging and optical resolution constrain individual trajectories; dynamics alone cannot define a causal continuous scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC4.

### [50] G-tract RNA removes Polycomb repressive complex 2 from genes.

**Shows:** G-tract RNA competes PRC2 off nucleosomes and targeted CDKN2A RNA releases repression.

**Does not show:** Other genes and tumor contexts do not imply every Xist interaction is inhibitory; linked correction metadata is retained.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. ErratumIn: PMID31695189. Subclaims: SC2.

### [51] Targeting of Polycomb Repressive Complex 2 to RNA by Short Repeats of Consecutive Guanines.

**Shows:** PRC2 preferentially recognizes G tracts and folded quadruplex RNA.

**Does not show:** Affinity and enrichment cannot establish a native selective Xist tether or causal output.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [52] Promiscuous RNA binding by Polycomb repressive complex 2.

**Shows:** PRC2 binds relevant and irrelevant RNA with comparable length-dependent affinity.

**Does not show:** Promiscuity limits specificity inference without excluding regulated contacts in native cells.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [53] The interaction of PRC2 with RNA or chromatin is mutually antagonistic.

**Shows:** RNA and chromatin/nucleosomes compete for PRC2 and RNA loss alters recruitment patterns.

**Does not show:** RNase-based chromatin inference requires later normalization controls; competition does not forbid transient RNA-mediated regulation.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [54] Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA.

**Shows:** RepA binding and nonspecific RNA binding coexist; assay conditions alter affinities and an examined recruitment interpretation was PRC2-independent.

**Does not show:** The paper contains experimental binding work despite its title; it does not demonstrate in-vivo motif-specific tethering.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [55] The apparent loss of PRC2 chromatin occupancy as an artifact of RNA depletion.

**Shows:** RNase-induced background DNA redistribution can artifactually reduce PRC2 and H3K27me3 ChIP occupancy.

**Does not show:** The artifact applies to this assay, not all RNA-binding or recruitment experiments.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [56] Conserved RNA-binding specificity of polycomb repressive complex 2 is achieved by dispersed amino acid patches in EZH2.

**Shows:** Dispersed EZH2 residues mediate RNA recognition with conserved quadruplex preference.

**Does not show:** In-vitro separation of binding does not alone prove Xist-specific silencing and both-complex structural tethering.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [57] Molecular analysis of PRC2 recruitment to DNA in chromatin and its inhibition by RNA.

**Shows:** Linker DNA dominates substrate binding and RNA competitively sequesters PRC2 from nucleosomes.

**Does not show:** A purified competition model cannot alone settle the full native Xi recruitment cascade.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2.

### [58] Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome.

**Shows:** Structured RepA binds recombinant PRC2; knockdown also severely impairs full-length Xist induction, and PRC2-deficient Xist-positive cells can retain silencing.

**Does not show:** Expression confounding and indirect cellular associations prevent the knockdown from isolating a direct necessary continuous scaffold.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Main text:paragraph7, 1:Main text:paragraph8, 1:Main text:paragraph9, 1:Main text:paragraph10, 1:Main text:paragraph11. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [59] Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing.

**Shows:** RING1B-dependent H2A ubiquitination persists without EED/H3K27me3 and is independent of silencing.

**Does not show:** Independent PRC1 recruitment in this context does not imply all PRC complexes act independently in every lineage.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [60] Independent domains for recruitment of PRC1 and PRC2 by human XIST.

**Shows:** Different RNA regions and enzymatic inhibitors separate human PRC1/SMCHD1 and PRC2/macroH2A pathways at autosomal and X-linked integration sites.

**Does not show:** Cancer cells ectopic induction and incomplete global inhibition limit species-general transfer; independence does not demonstrate direct binding.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph0, 1:Results:paragraph7, 1:Results:paragraph10, 1:Results:paragraph13, 1:Results:paragraph14, 1:Results:paragraph16, 1:Results:paragraph18. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [61] Isogenic comparison of Airn and Xist reveals core principles of Polycomb recruitment by lncRNAs.

**Shows:** In an isogenic ectopic-transgene comparison in mouse embryonic stem cells, Airn deposits Polycomb marks without repression; adding Xist A-repeat restores repression, and in-cell RIP favors hnRNPK-bridged PRC1 association.

**Does not show:** Formaldehyde RIP detects direct and indirect interactions; the transgenes are expressed from an ectopic locus in mouse embryonic stem cells, so weak PRC2 signals do not negate UV-supported contact obtained with different assay chemistry at the endogenous locus.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:Results:paragraph5, 1:Results:paragraph12, 1:Results:paragraph15, 1:Results:paragraph17, 1:Results:paragraph29, 1:Results:paragraph30. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [62] G-quadruplex folding in Xist RNA antagonizes PRC2 activity for stepwise regulation of X chromosome inactivation.

**Shows:** rG4 loss preserves direct UV-supported PRC2 association but deregulates marks and silencing; mutants preserving RNA expression avoid the AF confound.

**Does not show:** A regulated direct contact supports dynamic catalysis, not direct binding to both complexes or continuous structural tethering; assays need independent replication.

**Access/status:** Complete primary abstract and linked-status metadata examined. Selected body sections: 1:RESULTS:paragraph7, 1:RESULTS:paragraph8, 1:RESULTS:paragraph10, 1:RESULTS:paragraph11, 1:RESULTS:paragraph14, 1:RESULTS:paragraph16. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [63] The Xist RNA-PRC2 complex at 20-nm resolution reveals a low Xist stoichiometry and suggests a hit-and-run mechanism in mouse cells.

**Shows:** Sparse Xist/PRC2 hubs and reassociation support a dynamic spatial interaction and hit-and-run model.

**Does not show:** Nonrandom nanoscale proximity is not itself direct molecular binding; finite detection cannot rule out all undetected RNA.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4.

### [64] Systematic allelic analysis defines the interplay of key pathways in X chromosome inactivation.

**Shows:** SPEN dominates many genes while Polycomb supports pre-marked genes; LBR and m6A factors have minor tested contributions.

**Does not show:** Shared Oxford platforms are not wholly independent replications and gene-class dependence opposes universal scaffold necessity.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3.

### [65] Xist Deletional Analysis Reveals an Interdependency between Xist RNA and Polycomb Complexes for Spreading along the Inactive X.

**Shows:** Repeat B/HNRNPK and Polycomb reciprocally support RNA spreading, silencing and Xi topology.

**Does not show:** Feedback dependence supports cooperation but does not discriminate a direct continuous tether from adapter recruitment or compaction.

**Access/status:** Complete primary abstract and linked-status metadata examined. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4.